These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 32461198)

  • 21. [Role of age, comorbidity and renin- angiotensin-aldosterone system in COVID-19. Effects of ACE inhibitors and angiotensin receptor blockers].
    Mareev YV; Mareev VY
    Kardiologiia; 2020 Apr; 60(4):4-9. PubMed ID: 32394850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin receptor blockers for the treatment of COVID-19 and its comorbidities.
    Saavedra JM
    Pharmacol Res; 2020 Sep; 159():104958. PubMed ID: 32473311
    [No Abstract]   [Full Text] [Related]  

  • 23. Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study.
    Conversano A; Melillo F; Napolano A; Fominskiy E; Spessot M; Ciceri F; Agricola E
    Hypertension; 2020 Aug; 76(2):e10-e12. PubMed ID: 32383626
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibitors of the renin-angiotensin system: The potential role in the pathogenesis of COVID-19.
    Huang Z; Jiang Y; Chen J; Zhou Y
    Cardiol J; 2020; 27(2):171-174. PubMed ID: 32286678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Cross-Talk between Age, Hypertension and Inflammation in COVID-19 Patients: Therapeutic Targets.
    Casucci G; Acanfora D; Incalzi RA
    Drugs Aging; 2020 Nov; 37(11):779-785. PubMed ID: 33084001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 and relative angiotensin-converting enzyme 2 deficiency: role in disease severity and therapeutic response.
    Ryan PM; Caplice N
    Open Heart; 2020 Jun; 7(1):. PubMed ID: 32532804
    [No Abstract]   [Full Text] [Related]  

  • 27. Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients.
    Rossi GP; Sanga V; Barton M
    Elife; 2020 Apr; 9():. PubMed ID: 32250244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of ACE2 receptor and ACEIs/ARBs with disease severity in COVID-19.
    Sinha S; Sehgal A; Sehgal R
    Drug Discov Ther; 2020; 14(4):161-170. PubMed ID: 32908071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
    Cheng H; Wang Y; Wang GQ
    J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics of coronavirus disease 2019 (COVID-19) patients with hypertension on renin-angiotensin system inhibitors.
    Zhou X; Zhu J; Xu T
    Clin Exp Hypertens; 2020 Oct; 42(7):656-660. PubMed ID: 32404011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular molecular mechanisms of disease with COVID-19.
    Foo R; Wang Y; Zimmermann WH; Backs J; Wang DW
    J Mol Cell Cardiol; 2020 Apr; 141():107. PubMed ID: 32289321
    [No Abstract]   [Full Text] [Related]  

  • 32. Chronic obstructive pulmonary disease and the COVID-19 pandemic: Reciprocal challenges.
    Deslée G; Zysman M; Burgel PR; Perez T; Boyer L; Gonzalez J; Roche N;
    Respir Med Res; 2020 Nov; 78():100764. PubMed ID: 32498023
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical Characteristics and Prognosis of 244 Cardiovascular Patients Suffering From Coronavirus Disease in Wuhan, China.
    Peng Y; Meng K; He M; Zhu R; Guan H; Ke Z; Leng L; Wang X; Liu B; Hu C; Ji Q; Keerman M; Cheng L; Wu T; Huang K; Zeng Q
    J Am Heart Assoc; 2020 Oct; 9(19):e016796. PubMed ID: 32794415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronavirus disease 2019 infection and the cardiovascular system.
    Romeo F; Calcaterra G; Barilla F; Mehta JL
    J Cardiovasc Med (Hagerstown); 2020 Jun; 21(6):403-405. PubMed ID: 32324641
    [No Abstract]   [Full Text] [Related]  

  • 35. [Renin-angiotensin-aldosterone blockers and Covic-19 infection : friends or enemies ?].
    Pechère-Bertschi A; Ponte B; Wuerzner G
    Rev Med Suisse; 2020 May; 16(693):1003-1007. PubMed ID: 32401442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What solid organ transplant healthcare providers should know about renin-angiotensin-aldosterone system inhibitors and COVID-19.
    Wong SY; Brubaker AL; Wang AX; Taiwo AA; Melcher ML
    Clin Transplant; 2020 Jul; 34(7):e13991. PubMed ID: 32446267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19, ACE2, and the cardiovascular consequences.
    South AM; Diz DI; Chappell MC
    Am J Physiol Heart Circ Physiol; 2020 May; 318(5):H1084-H1090. PubMed ID: 32228252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019.
    Sanchis-Gomar F; Lavie CJ; Perez-Quilis C; Henry BM; Lippi G
    Mayo Clin Proc; 2020 Jun; 95(6):1222-1230. PubMed ID: 32376099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility and prognosis of COVID-19 patients with cardiovascular disease.
    Wang BX
    Open Heart; 2020 Jun; 7(1):. PubMed ID: 32587104
    [No Abstract]   [Full Text] [Related]  

  • 40. Renin-angiotensin system blockers and severe acute respiratory syndrome coronavirus 2.
    Lévy BI; Fauvel JP;
    Arch Cardiovasc Dis; 2020; 113(8-9):572-578. PubMed ID: 32863157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.